Skip to main content

Leukemia MRD

Monitoring the success of your cancer treatment requires the highest level of microscopic precision to ensure you remain confidently on the path to long-term remission. Integrated into our elite Hematology and Oncology services, Leukemia MRD (Minimal Residual Disease) testing detects incredibly low levels of remaining cancer cells that standard microscopic tests cannot see. By leveraging highly sensitive molecular and flow cytometry technology, this vital screening provides definitive reassurance or early warning of relapse, safely guiding proactive adjustments to your personalized treatment plan. Trusted for sensitive oncological monitoring across diagnostic labs in the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical accuracy, and prompt, dependable reporting. Protect your hematological recovery—schedule your leukemia MRD testing in UAE, coordinate a secure sample collection, or consult our specialized hematology-oncology professionals today.

AML ETO t(8;21) Gene Rearrangement Quantitative MRD Monitor Test

AML ETO t(8;21) Gene Rearrangement Quantitative MRD Monitor Test Executive Summary & Core Metr...

1,000 AED

Minimal Residual Disease (MRD) Analysis for T-ALL Test

Minimal Residual Disease (MRD) Analysis for T-ALL in UAE | 2500 AED | DHA Licensed Executive S...

2,500 AED

NPM1 Gene Mutation Quantitative MRD Monitor Test

NPM1 Gene Mutation Quantitative MRD Monitor Test in UAE | 850 AED Executive Summary & Core...

850 AED